Form 4: Oscar Health CLO Sells Shares for Tax Obligations

Oscar Health's Chief Legal Officer, Adam McAnaney, sold shares of Class A Common Stock to cover tax withholding obligations from vested equity awards.

Summary

• Adam McAnaney, Chief Legal Officer of Oscar Health, Inc. (OSCR), sold a total of 9,859 shares of Class A Common Stock on June 2, 2026.
• The sales were executed in two separate transactions: 7,065 shares at a weighted average price of $21.74 per share and 2,794 shares at a weighted average price of $22.45 per share.
• The total value of the shares sold was approximately $216,318.40.
• These transactions were conducted pursuant to a Rule 10b5-1 instruction letter entered into on August 8, 2025, specifically to satisfy tax withholding obligations upon the vesting of previously granted equity awards.
• Following these reported transactions, Mr. McAnaney beneficially owns 218,096 shares of Oscar Health Class A Common Stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The sale is a routine, pre-planned transaction for tax purposes related to equity award vesting, which is a common occurrence for executives and does not reflect on the company's operational performance or future prospects.

Positives

• The underlying vesting of equity awards indicates compensation for the Chief Legal Officer, which is a standard practice for executive retention and motivation.

Negatives

• The sale of shares by an insider, even for tax purposes, can sometimes be perceived as a lack of confidence, though this is mitigated by the stated reason and the pre-arranged Rule 10b5-1 plan.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic outlook.

Management Comments

• The sale was effected pursuant to a Rule 10b5-1 instruction letter entered into on August 8, 2025, to satisfy the Reporting Person's tax withholding obligation upon the vesting of previously granted equity awards.

Industry Context

StockSavvy.ai notes that insider sales for tax withholding purposes, especially when executed under a pre-arranged Rule 10b5-1 plan, are common and generally considered routine events in the public markets. They typically do not reflect a change in the company's operational performance or strategic direction, nor do they usually signal a lack of confidence from the insider.

Stakeholder Impact

• Shareholders: Minimal direct impact, as this is a routine, pre-planned insider sale for tax purposes and does not signal a change in company fundamentals or outlook.
• Employees: No direct impact indicated by this filing.

Key Dates

Recommendation

This Form 4 filing details a routine insider sale by Oscar Health's Chief Legal Officer to cover tax obligations from vested equity awards, executed under a Rule 10b5-1 plan. Such transactions are common and generally do not reflect on the company's operational performance or future prospects. Therefore, this filing alone does not provide a basis for changing an investment recommendation, and a 'hold' stance is appropriate, pending further company-specific or market-wide developments.

Keywords

Oscar Health, OSCR, Insider Transaction, Form 4, Stock Sale, Equity Awards, Tax Withholding, Adam McAnaney, Chief Legal Officer, 10b5-1 Plan